DiaMedica Therapeutics Inc.
DMACNasdaqCIK 1401040HealthcareFiscal year ends Dec 31
Reports and events: 125 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-02-1316:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-20-002598 |
| 2020-02-1107:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-20-002240 |
| 2020-01-0308:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-20-000102 |
| 2019-11-1316:17 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001437749-19-022682 |
| 2019-11-1316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-19-022681 |
| 2019-10-3016:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-19-020938 |
| 2019-08-1317:16 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001437749-19-016595 |
| 2019-08-1316:27 ET | 8-K | 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-19-016566 |
| 2019-06-2116:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-19-012427 |
| 2019-06-1916:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-19-012278 |
| 2019-06-0407:30 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-19-011313 |
| 2019-05-2316:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-19-010747 |
| 2019-05-1316:50 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001437749-19-009677 |
| 2019-05-1316:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-19-009676 |
| 2019-04-0806:04 ET | DEF 14A | Proxy statementPeriod 2019-05-22 | 0001437749-19-006692 |
| 2019-03-1917:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-19-005268 |
| 2019-03-1916:58 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001437749-19-005272 |
| 2019-02-2608:01 ET | 8-K | 8.01 Other events | 0001437749-19-003322 |
| 2019-01-0917:00 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-19-000614 |
| 2019-01-0307:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-19-000116 |
| 2018-12-1116:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-18-021894 |
| 2018-11-2807:31 ET | S-1/A | Registration statement, amended | 0001437749-18-021321 |
| 2018-11-2707:31 ET | S-1/A | Registration statement, amended | 0001437749-18-021292 |
| 2018-11-1917:01 ET | S-1/A | Registration statement, amended | 0001437749-18-021086 |
| 2018-11-0916:21 ET | S-1 | Registration statement | 0001437749-18-020300 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.